11. Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy. Issue 6 (June 2022) Authors: Bomze, David; Mutti, Luciano; Goldman, Adam; Markel, Gal; Meirson, Tomer Journal: Lancet oncology Issue: Volume 23:Issue 6(2022) Page Start: e245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex. Issue 6 (June 2014) Authors: Greenberg, Eyal; Hajdu, Steven; Nemlich, Yael; Cohen, Ronit; Itzhaki, Orit; Jacob-Hirsch, Jasmine; Besser, Michal J.; Schachter, Jacob; Markel, Gal Journal: Open biology Issue: Volume 4:Issue 6(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients. Issue 1 (8th March 2020) Authors: Itzhaki, Orit; Jacoby, Elad; Nissani, Abraham; Levi, Michal; Nagler, Arnon; Kubi, Adva; Brezinger, Karin; Brayer, Hadar; Zeltzer, Li-at; Rozenbaum, Meir; Vernitsky, Helly; Markel, Gal; Toren, Amos; Avigdor, Abraham; Schachter, Jacob; Besser, Michal J Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Highlights from the latest articles in pharmacogenomics research. (June 2014) Authors: Markel, Gal; Galore-Haskel, Gilli; Sullivan, Ryan Journal: Pharmacogenomics Issue: Volume 15:Number 8(2014) Page Start: 1063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions. (1st January 2020) Authors: Baruch, Erez Nissim; Ortenberg, Rona; Avivi, Camila; Anafi, Liat; Dick-Necula, Daniela; Stossel, Chani; Moshkovits, Yonatan; Itzhaki, Orit; Besser, Michal Judith; Schachter, Jacob; Barshack, Iris; Markel, Gal Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients. (February 2019) Authors: Ben-Betzalel, Guy; Steinberg-Silman, Yael; Stoff, Ronen; Asher, Nethanel; Shapira-Frommer, Ronnie; Schachter, Jacob; Markel, Gal Journal: European journal of cancer Issue: Volume 108(2019) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy. Issue 4 (1st February 2022) Authors: Shouval, Roni; Alarcon Tomas, Ana; Fein, Joshua A.; Flynn, Jessica R.; Markovits, Ettai; Mayer, Shimrit; Olaide Afuye, Aishat; Alperovich, Anna; Anagnostou, Theodora; Besser, Michal J.; Batlevi, Connie Lee; Dahi, Parastoo B.; Devlin, Sean M.; Fingrut, Warren B.; Giralt, Sergio A.; Lin, Richard J.... Journal: Journal of clinical oncology Issue: Volume 40:Issue 4(2022) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Informative censoring of surrogate end-point data in phase 3 oncology trials. (August 2021) Authors: Gilboa, Shai; Pras, Yarden; Mataraso, Aviv; Bomze, David; Markel, Gal; Meirson, Tomer Journal: European journal of cancer Issue: Volume 153(2021) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes. Issue 5 (June 2016) Authors: Ben-Avi, Ronny; Itzhaki, Orit; Simansky, David; Zippel, Dov; Markel, Gal; Ben Nun, Alon; Schachter, Jacob; Besser, Michal J. Journal: Journal of immunotherapy Issue: Volume 39:Issue 5(2016:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. (1st January 2020) Authors: de Azevedo, Ricardo A.; Shoshan, Einav; Whang, Shanzhi; Markel, Gal; Jaiswal, Ashvin R.; Liu, Arthur; Curran, Michael A.; Travassos, Luiz R.; Bar-Eli, Menashe Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗